April 2022
Strategy The index revolution (finally) comes to hedge funds
One common knock on factor models is that they “replicate only beta” – not the pure alpha gold that allocators seek. This critique pre-dates the appreciation of factor rotations. Outside of some ivory tower statistics class, no one questions the “alpha” generated by, for (...)
|
February 2022
Strategy We have reduced our equity exposure through option strategies
Samir Saadi, Multi-Asset Portfolio Manager of CPR AM explains that he started the year heavily invested in equities to capture the good momentum of this beginning of the year. Convinced that the year would be special, CPR AM introduced optional hedging (...)
|
November 2021
Strategy Deforestation: engaging to preserve the world’s “carbon sink”
NN Investment Partners (NN IP) has signed the financial sector commitment letter on eliminating commodity-driven deforestation. The letter commits us to making best efforts to eliminate forest-risk agricultural commodity-driven deforestation activities at the companies in (...)
|
October 2021
Strategy How are hedge funds positioning after the market correction?
L/S Equity managers have decently navigated these markets, generating small positive alpha (especially on their short positions) but their implicit stance is diverging across regions. U.S. managers detracted only marginal alpha. They maintained their modest overall exposures (...)
|
August 2021
Strategy L/S China through regulatory and business upheaval
Trading conditions in China have severely deteriorated. After reaching their peak by mid-February, stocks lost earlier gains in March, on evidence of a plateauing economy and as stretched investors’ positioning unwounded. Chinese markets were then stuck in a volatile trading (...)
|
July 2021
Strategy Investing in growth stocks
For an investor, investing in growth stocks can be a particularly wise choice over the long term. But it can also be a useful tactic within a portfolio diversification strategy, particularly if the companies adhere to certain ethical criteria. This responsible investment (...)
|
June 2021
Strategy Mega Mergers to keep fueling Risk Arbitrage
With risk assets back to record highs, markets are currently looking for the next catalyst that would push equities higher. But with the Fed potentially signaling a looming reduction in asset purchases at the next FOMC meeting on June 16, it seems wise to remove some risk (...)
|
May 2021
Strategy Impact investing: Think long term, act now
ESG compliance or financial performance? While this may have been a choice in the past, today the point is obsolete. By recognizing the impact of our investments, we have taken an important step forward as we seek to reconcile responsibility and returns, and strike a balance (...)
|
May 2021
Strategy CTAs add value in the new correlation regime
With bond yields facing upward pressures as the global economy heats up, finding diversification across traditional asset classes has been increasingly difficult. Equity valuations, which were propelled by low interest rates in the past decade, are vulnerable in the face of (...)
|
May 2021
Strategy Japan Could Win a Medal in the Recovery Race
A strong manufacturing base and changing attitudes toward shareholder value could mean the world’s capital heads to Japan, even if the world’s sports fans cannot. The analysis of Erik L. Knutzen, CFA, CAIA, Chief Investment Officer—Multi-Asset Class, Neuberger (...)
|
May 2021
Strategy Are L/S Equity Managers playing the European Recovery?
Economic prospects in Europe are noticeably improving. The new wave of virus infections since late fall 2020 led to tighter mobility restrictions, which delayed the European recovery. High frequency indicators suggest economic activity was down around 20% from normal over (...)
|
May 2021
Strategy Event-Driven stays alluring despite the SPAC slowdown
Event-Driven strategies saw exciting developments in recent quarters, in a context where global M&A volumes saw the strongest start to the year ever. Global M&A volumes, close to USD 1.5 trillion year-to-date, were fueled by a flurry of U.S. acquisitions and Special (...)
|
April 2021
Strategy Value, Momentum and the Outlook for Market Neutral L/S
Momentum stocks experienced a correction since Pfizer announced their Covid-19 vaccine results early November. Performance has nonetheless stabilized over the course of March, as the rebound in Value stocks has been persistent and started to be shown in the Momentum risk (...)
|
March 2021
Strategy CTAs Rally despite dreadful momentum in Equity Markets
With investors questioning the sustainability of equity valuations in a context of rising bonds yields, a Momentum reversal in equities is taking shape. Defensive sectors, and more recently Technology stocks, faced downward pressures while Financials and Energy (...)
|
February 2021
Strategy Market neutral l/sto remain under pressure
In recent months, Market Neutral L/S strategies underperformed other hedge fund strategies, in a context where risk assets rallied following the Pfizer vaccine announcement in November 2020. While the strategy is not designed to capture the equity market beta, the alpha (...)
|
| 1
|
|
|
|
|
|
|
|
|
| |
Read comments
